ZA857783B - Stabilized injectable solutions of piroxicam - Google Patents

Stabilized injectable solutions of piroxicam

Info

Publication number: ZA857783B
Authority: ZA; South Africa
Prior art keywords: piroxicam; solutions; injectable solutions; stabilized injectable; stabilized
Prior art date: 1984-10-10

Application number

ZA857783A

Other languages

English (en)

Inventor

Walter Fries

Original Assignee

Mack Chem Pharm

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-10-10

Filing date

1985-10-09

Publication date

1987-05-27

1985-10-09 Application filed by Mack Chem Pharm filed Critical Mack Chem Pharm

1987-05-27 Publication of ZA857783B publication Critical patent/ZA857783B/xx

Links

QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 title abstract 3
229960002702 piroxicam Drugs 0.000 title abstract 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 abstract 2
239000000243 solution Substances 0.000 abstract 2
MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 abstract 1
239000007864 aqueous solution Substances 0.000 abstract 1
WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 abstract 1
238000007911 parenteral administration Methods 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
239000002904 solvent Substances 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Dermatology (AREA)
Engineering & Computer Science (AREA)
Rheumatology (AREA)
Organic Chemistry (AREA)
Pain & Pain Management (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Finger-Pressure Massage (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)

ZA857783A 1984-10-10 1985-10-09 Stabilized injectable solutions of piroxicam ZA857783B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19843437232 DE3437232A1 (de)	1984-10-10	1984-10-10	Stabilisierte injektionsloesungen von piroxicam

Publications (1)

Publication Number	Publication Date
ZA857783B true ZA857783B (en)	1987-05-27

Family

ID=6247603

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA857783A ZA857783B (en)	1984-10-10	1985-10-09	Stabilized injectable solutions of piroxicam

Country Status (22)

Country	Link
US (1)	US4628053A (ja)
EP (1)	EP0177870B1 (ja)
JP (1)	JPS6191116A (ja)
KR (1)	KR890001001B1 (ja)
CN (1)	CN85107838B (ja)
AT (1)	ATE62416T1 (ja)
AU (1)	AU557184B2 (ja)
CA (1)	CA1251734A (ja)
DD (1)	DD238329A5 (ja)
DE (2)	DE3437232A1 (ja)
DK (1)	DK165901C (ja)
FI (1)	FI84315C (ja)
GR (1)	GR852439B (ja)
HU (1)	HU195111B (ja)
IE (1)	IE58267B1 (ja)
IL (1)	IL76624A0 (ja)
NO (1)	NO166687C (ja)
NZ (1)	NZ213758A (ja)
PH (1)	PH23058A (ja)
PT (1)	PT81264B (ja)
SU (1)	SU1482509A3 (ja)
ZA (1)	ZA857783B (ja)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2545910B1 (fr) *	1983-05-11	1988-07-22	Valeo	Dispositif pour ameliorer l'efficacite d'un echangeur de chaleur dans un boitier d'une installation de climatisation, et boitier de cette installation
IT1196307B (it) *	1984-10-22	1988-11-16	Chiesi Farma Spa	Formulazioni farmaceutiche acquose di piroxicam monoidrato
US5807568A (en) *	1994-12-27	1998-09-15	Mcneil-Ppc, Inc.	Enhanced delivery of topical compositions containing flurbiprofen
IT1283252B1 (it) *	1996-03-15	1998-04-16	Pulitzer Italiana	Soluzioni di piroxicam iniettabili per via parenterale
WO1998001138A1 (fr) *	1996-07-04	1998-01-15	Nippon Kayaku Kabushiki Kaisha	Injections de succinate sodique de methylprednisolone
US6136799A (en) *	1998-04-08	2000-10-24	Abbott Laboratories	Cosolvent formulations
DE10030345A1 (de) *	2000-06-20	2002-01-10	Boehringer Ingelheim Vetmed	Hochkonzentrierte stabile Meloxicamlösungen
US20020035107A1 (en)	2000-06-20	2002-03-21	Stefan Henke	Highly concentrated stable meloxicam solutions
DE10161077A1 (de) *	2001-12-12	2003-06-18	Boehringer Ingelheim Vetmed	Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en)	2002-10-25	2015-03-31	Boehringer Ingelheim Vetmedica Gmbh	Water-soluble meloxicam granules
US8314124B2 (en) *	2004-02-06	2012-11-20	Active Biotech Ab	Crystalline salts of quinoline compounds and methods for preparing them
EP1568369A1 (en)	2004-02-23	2005-08-31	Boehringer Ingelheim Vetmedica Gmbh	Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004021281A1 (de) *	2004-04-29	2005-11-24	Boehringer Ingelheim Vetmedica Gmbh	Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) *	2004-06-23	2006-01-26	Boehringer Ingelheim Vetmedica Gmbh	Neue Verwendung von Meloxicam in der Veterinärmedizin
NZ567627A (en) *	2005-09-30	2011-08-26	Boehringer Ingelheim Vetmed	Granulation process for making a divisible tablet containing meloxicam
SG10201508623RA (en) *	2005-10-19	2015-11-27	Teva Pharma	Crystals of laquinimod sodium, and process for the manufacture thereof
KR20150065951A (ko) *	2006-06-12	2015-06-15	테바 파마슈티컬 인더스트리즈 리미티드	안정한 라퀴니모드 제제
WO2009082471A1 (en) *	2007-12-20	2009-07-02	Teva Pharmaceutical Industries, Ltd.	Stable laquinimod preparations
MX2011002033A (es) *	2008-09-03	2011-05-02	Teva Pharma	2-oxo-1,2-dihidro-quinolinas moduladoras de la funcion inmune.
JP5359333B2 (ja) *	2009-02-05	2013-12-04	ゼリア新薬工業株式会社	コロソリン酸含有水性液剤
ES2564931T3 (es) *	2009-07-30	2016-03-30	Teva Pharmaceutical Industries Ltd.	Tratamiento de enfermedad de Crohn con laquinimod
CA2771203C (en) *	2009-08-10	2019-04-09	Teva Pharmaceutical Industries Ltd.	Treatment of bdnf-related disorders using laquinimod
MX2012004177A (es)	2009-10-12	2012-05-08	Boehringer Ingelheim Vetmed	Recipiente para composiciones que comprenden meloxicam.
US9149480B2 (en)	2010-03-03	2015-10-06	Boehringer Ingeleheim Vetmedica GmbH	Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US20110218191A1 (en) *	2010-03-03	2011-09-08	Boehringer Ingelheim Vetmedica Gmbh	Use of meloxicam for the long term-treatment of kidney disorders in cats
DE102010014290A1 (de) *	2010-04-08	2011-10-13	Hans Otto Meyer zu Spelbrink	Mittel zur prophylaktischen und therapeutischen Behandlung von Herpes-Infektionen
US9795568B2 (en)	2010-05-05	2017-10-24	Boehringer Ingelheim Vetmedica Gmbh	Low concentration meloxicam tablets
EP2766020A4 (en)	2011-10-12	2015-04-01	Teva Pharma	TREATMENT OF MULTIPLE SCLEROSIS BY COMBINING LAQUINIMOD AND FINGOLIMOD
AR089862A1 (es)	2012-02-03	2014-09-24	Teva Pharma	USO DE LAQUINIMOD PARA EL TRATAMIENTO DE PACIENTES CON ENFERMEDAD DE CROHN EN QUIENES FRACASO UNA TERAPIA ANTI-FACTOR DE NECROSIS TUMORAL a (ANTI-TNFa) DE PRIMERA LINEA
TW201400117A (zh)	2012-06-05	2014-01-01	Teva Pharma	使用拉喹莫德治療眼發炎疾病
MX2015005632A (es)	2012-11-07	2016-02-05	Teva Pharma	Sales de amina de laquinimod.
EP2970129A2 (en)	2013-03-14	2016-01-20	Teva Pharmaceutical Industries Ltd.	Crystals of laquinimod sodium and improved process for the manufacture thereof
KR101749425B1 (ko) *	2015-11-17	2017-06-22	연세대학교 산학협력단	난용성 약물의 서방형 제제
FI3664800T3 (fi) *	2017-08-09	2024-08-07	Dechra Veterinary Products Llc	Cox-2-estäjää käsittäviä terapeuttisia formulaatioita ja niiden käyttötarkoituksia

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE629650A (ja) *	1967-05-18	1900-01-01
US3591584A (en) *	1968-08-27	1971-07-06	Pfizer	Benzothiazine dioxides
DE2602363C2 (de) *	1976-01-22	1984-04-12	Bayer Ag, 5090 Leverkusen	Wäßrige, injizierbare Niclofolan- Formulierungen
DE2756113A1 (de) *	1977-12-16	1979-06-21	Thomae Gmbh Dr K	Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE3217315C2 (de) *	1982-05-08	1986-05-22	Gödecke AG, 1000 Berlin	Arzneimittelzubereitungen mit einem Gehalt an Oxicam-Derivaten
AT376879B (de) *	1982-10-27	1985-01-10	Gerot Pharmazeutika	Verfahren zur herstellung einer injektionsloesung

1984
- 1984-10-10 DE DE19843437232 patent/DE3437232A1/de not_active Ceased
1985
- 1985-09-30 EP EP85112378A patent/EP0177870B1/de not_active Expired - Lifetime
- 1985-09-30 DE DE8585112378T patent/DE3582468D1/de not_active Expired - Fee Related
- 1985-09-30 AT AT85112378T patent/ATE62416T1/de not_active IP Right Cessation
- 1985-10-07 US US06/784,903 patent/US4628053A/en not_active Expired - Fee Related
- 1985-10-08 GR GR852439A patent/GR852439B/el unknown
- 1985-10-08 PT PT81264A patent/PT81264B/pt not_active IP Right Cessation
- 1985-10-08 KR KR1019850007399A patent/KR890001001B1/ko not_active Expired
- 1985-10-08 CA CA000492481A patent/CA1251734A/en not_active Expired
- 1985-10-08 JP JP60224617A patent/JPS6191116A/ja active Granted
- 1985-10-09 SU SU853966192A patent/SU1482509A3/ru active
- 1985-10-09 ZA ZA857783A patent/ZA857783B/xx unknown
- 1985-10-09 DD DD85281570A patent/DD238329A5/de not_active IP Right Cessation
- 1985-10-09 HU HU853920A patent/HU195111B/hu not_active IP Right Cessation
- 1985-10-09 NO NO854011A patent/NO166687C/no unknown
- 1985-10-09 NZ NZ213758A patent/NZ213758A/xx unknown
- 1985-10-09 CN CN85107838A patent/CN85107838B/zh not_active Expired
- 1985-10-09 DK DK461385A patent/DK165901C/da not_active IP Right Cessation
- 1985-10-09 IE IE248385A patent/IE58267B1/en not_active IP Right Cessation
- 1985-10-09 AU AU48421/85A patent/AU557184B2/en not_active Ceased
- 1985-10-09 IL IL76624A patent/IL76624A0/xx not_active IP Right Cessation
- 1985-10-09 FI FI853926A patent/FI84315C/fi not_active IP Right Cessation
- 1985-10-09 PH PH32905A patent/PH23058A/en unknown

Also Published As

Publication number	Publication date
NZ213758A (en)	1988-07-28
EP0177870A3 (en)	1987-06-03
EP0177870A2 (de)	1986-04-16
PT81264A (en)	1985-11-01
FI84315C (fi)	1991-11-25
JPS6191116A (ja)	1986-05-09
PT81264B (pt)	1988-02-17
DK461385D0 (da)	1985-10-09
IE58267B1 (en)	1993-08-25
NO854011L (no)	1986-04-11
GR852439B (ja)	1986-02-10
NO166687B (no)	1991-05-21
CN85107838A (zh)	1986-07-09
DE3437232A1 (de)	1986-04-17
IE852483L (en)	1986-04-10
CN85107838B (zh)	1988-08-24
CA1251734A (en)	1989-03-28
IL76624A0 (en)	1986-02-28
DD238329A5 (de)	1986-08-20
FI853926A0 (fi)	1985-10-09
DK165901B (da)	1993-02-08
DK461385A (da)	1986-04-11
AU557184B2 (en)	1986-12-11
HUT38541A (en)	1986-06-30
DK165901C (da)	1993-06-28
NO166687C (no)	1991-09-04
US4628053A (en)	1986-12-09
FI84315B (fi)	1991-08-15
HU195111B (en)	1988-04-28
ATE62416T1 (de)	1991-04-15
PH23058A (en)	1989-03-27
KR860003013A (ko)	1986-05-19
EP0177870B1 (de)	1991-04-10
AU4842185A (en)	1986-04-17
SU1482509A3 (ru)	1989-05-23
FI853926L (fi)	1986-04-11
DE3582468D1 (de)	1991-05-16
KR890001001B1 (ko)	1989-04-18
JPH03849B2 (ja)	1991-01-09

Publication	Publication Date	Title
IL76624A0 (en)	1986-02-28	Stabilized injectable solutions of piroxicam
SE8402560L (sv)	1984-11-14	Farmaceutisk komposition
PL300194A1 (en)	1994-04-05	Interferon conjugate, method of obtaining same and pharmaceutical composition containing it
CS653586A3 (en)	1992-10-14	Pharmaceutical containing 7-isopropoxyisoflavone
NZ219380A (en)	1990-06-26	(n-piperidinyl)- and (n-piperazinyl)-methylazole derivatives and pharmaceutical compositions
EP0191133A3 (en)	1987-01-07	Stable salts of sam with polyanions
IT8119321A0 (it)	1981-01-26	Procedimento per ottenere eparine di basso peso molecolare dotate di proprieta' farmacologiche elevate, e prodotto cosi' ottenuto.
IE831611L (en)	1984-01-13	Topical anti-inflammatory compositions
DE59208974D1 (de)	1997-11-20	Neue pyrazinderivative, ihre herstellung und verwendung
IL83086A (en)	1991-03-10	Stable,injectable solutions of vincristine salts
DE3767114D1 (de)	1991-02-07	Stabilisierte arzneimittel.
AU4478485A (en)	1986-01-16	2-phenoxymethyl-imidazoline derivatives
IT8121654A0 (it)	1981-05-12	Derivati tiazolidinici ad attivita' farmacologica, procedimento per la loro preparazione e composizioni farmaceutiche contenenti detti derivati.
GB985773A (en)	1965-03-10	Improvements in or relating to coated medicinals
ATE1011T1 (de)	1982-05-15	5-fluoruracil-derivate, deren herstellung und ihre pharmazeutischen zusammensetzungen.
FR2592653A1 (fr)	1987-07-10	Derives de chromene, procede d'obtention et compositions pharmaceutiques.
ATE44734T1 (de)	1989-08-15	4-phenylpropylindolderivate und ihre salze, verfahren zur herstellung, deren anwendung als heilmittel und sie enthaltende pharmazeutische zusammensetzungen.